BioAge Labs, Inc. BIOA
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
BioAge Labs Inc. is a biotechnology company focused on discovering and developing therapies that can enhance the human lifespan and address age-related diseases. By leveraging advanced technologies like artificial intelligence and genomics, BioAge Labs aims to pinpoint key molecular drivers of aging. Its approach invol…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees60
TickerBIOA
Statistics
Market Cap$885.5M
Revenue (TTM)$9.0M
Net Income-$80.6M
Net Margin-896.1%
EPS$-2.24
P/E1.38
P/S66.70
P/B1.81
EV/EBITDA-3.04
ROE-26.0%
Dividend Yield—
Price$19.95
Data: Twelve Data · Revenue = mcap / P/S